EUVIMEDEUVIMED entdecken
Metaanalyse

Clinical metabolomics characteristics of diabetic kidney disease: A meta‐analysis of 1875 cases with diabetic kidney disease and 4503 controls

Yu Yuan, Liping Huang, Lulu Yu, Xingxu Yan, Siyu Chen, Chenghao Bi, Junjie He, Yiqing Zhao, Liu Yang, Li Ning, Hua Jin, Rongrong Yang und 1 weitere

Diabetes/Metabolism Research and Reviews · 2024-03 · 40 (3)

DOI: 10.1002/dmrr.3789 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Diabetes/Metabolism Research and Reviews, online erschienen am 19.03.2024. Verfasst von Yu Yuan und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Kidney Failure, Chronic, Diabetes Mellitus. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: State Administration of Traditional Chinese Medicine Young Qihuang Scholars Support Program, Tianjin Talent Development Special Support Project for High-Level Innovation and Entrepreneurship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Diabetic Kidney Disease (DKD), one of the major complications of diabetes, is also a major cause of end‐stage renal disease. Metabolomics can provide a unique metabolic profile of the disease and thus predict or diagnose the development of the disease. Therefore, this study summarises a more comprehensive set of clinical biomarkers related to DKD to identify functional metabolites significantly associated with the development of DKD and reveal their driving mechanisms for DKD. Materials and Methods We searched PubMed, Embase, the Cochrane Library and Web of Science databases through October 2022. A meta‐analysis was conducted on untargeted or targeted metabolomics research data based on the strategy of standardized mean differences and the process of ratio of means as the effect size, respectively. We compared the changes in metabolite levels between the DKD patients and the controls and explored the source of heterogeneity through subgroup analyses, sensitivity analysis and meta‐regression analysis.

Results

The 34 clinical‐based metabolomics studies clarified the differential metabolites between DKD and controls, containing 4503 control subjects and 1875 patients with DKD. The results showed that a total of 60 common differential metabolites were found in both meta‐analyses, of which 5 metabolites ( p < 0.05) were identified as essential metabolites. Compared with the control group, metabolites glycine, aconitic acid, glycolic acid and uracil decreased significantly in DKD patients; cysteine was significantly higher. This indicates that amino acid metabolism, lipid metabolism and pyrimidine metabolism in DKD patients are disordered.

Conclusions

We have identified 5 metabolites and metabolic pathways related to DKD which can serve as biomarkers or targets for disease prevention and drug therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NephropathiesKidney Failure, ChronicDiabetes MellitusHumansMetabolomicsMetabolomeBiomarkers

Stichwörter der Autor:innen

biomarkersdiabetic kidney diseasemeta-analysismetabolomicssystematic review

Substanzen

Biomarkers

Autor:innen und Institutionen

  • State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • College of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • Department Clinical Laboratory, The Second Hospital of Tianjin Medical University, Tianjin, China.
  • Public Health Science and Engineering College, Tianjin University of Traditional Chinese Medicine, Tianjin, China.

ORCID-Profile: Yubo Li

Förderung

  • State Administration of Traditional Chinese Medicine Young Qihuang Scholars Support Program
  • Tianjin Talent Development Special Support Project for High-Level Innovation and Entrepreneurship

Zitieren

APA

Yuan, Y., Huang, L., Yu, L., Yan, X., Chen, S., Bi, C., He, J., Zhao, Y., Yang, L., Ning, L., Jin, H., Yang, R., & Li, Y. (2024). Clinical metabolomics characteristics of diabetic kidney disease: A meta‐analysis of 1875 cases with diabetic kidney disease and 4503 controls. Diabetes/Metabolism Research and Reviews, 40(3). https://doi.org/10.1002/dmrr.3789

Vancouver

Yuan Y, Huang L, Yu L, Yan X, Chen S, Bi C, et al. Clinical metabolomics characteristics of diabetic kidney disease: A meta‐analysis of 1875 cases with diabetic kidney disease and 4503 controls. Diabetes/Metabolism Research and Reviews. 2024;40(3). doi:10.1002/dmrr.3789

BibTeX
@article{Yuan2024,
  author = {Yuan, Yu and Huang, Liping and Yu, Lulu and Yan, Xingxu and Chen, Siyu and Bi, Chenghao and He, Junjie and Zhao, Yiqing and Yang, Liu and Ning, Li and Jin, Hua and Yang, Rongrong and Li, Yubo},
  title = {Clinical metabolomics characteristics of diabetic kidney disease: A meta‐analysis of 1875 cases with diabetic kidney disease and 4503 controls},
  journal = {Diabetes/Metabolism Research and Reviews},
  year = {2024},
  volume = {40},
  number = {3},
  doi = {10.1002/dmrr.3789}
}
Kostenlos starten →